COVID 'Cicada' Variant: New Risks for Children in India?
BA.3.2 subvariant poses higher infection risk to children despite low overall threat.
Top Summary
- What happened: A new COVID-19 subvariant, BA.3.2 (nicknamed 'Cicada'), has emerged, raising concerns about potential health risks, particularly for children.
- Why it matters: The 'Cicada' variant, with over 70 spike protein mutations, may evade existing vaccine antibodies, making children more susceptible to infection.
- What changes for people: Increased vigilance and adherence to COVID-19 safety protocols are crucial, especially for families with young children. Booster doses are recommended for eligible individuals.
- Who is affected: Primarily children with underdeveloped immune systems, but also immunocompromised individuals and the broader community due to potential spread.
The 'Cicada' Variant: A Closer Look
A new COVID-19 subvariant, BA.3.2, dubbed the 'Cicada' variant, is circulating globally. It was first detected in South Africa on November 22, 2024.
The 'Cicada' variant has more than 70 spike protein mutations. It has been found in wastewater samples across 25 US states, according to the CDC.
While the WHO and India's MoHFW, along with ICMR, currently assess the overall public health threat as low, concerns remain about its impact on children.
Why Children Are More Vulnerable
Studies suggest children are more susceptible to SARS-CoV-2 infection due to their developing immune systems.
The 'Cicada' variant reportedly infects children at a rate five times higher than adults, due to its mutated protein spikes that can evade current vaccine-induced antibodies.
Low booster dose coverage among children is a concern. As of recent data, approximately 33,011,876 children aged 12-14 have received the first dose, and 14,474,859 have received the second dose.
"There is no immediate threat to public health," according to the WHO and MoHFW, "but the variant could pose a risk to children."
Symptoms to Watch For
Symptoms of the 'Cicada' variant are similar to other COVID-19 strains:
- Cough
- Sore throat
- Congestion
- Shortness of breath
- Loss of taste and smell
- Vomiting
- Nausea
If these symptoms persist, especially after international travel, testing is recommended.
Protecting Children: Key Measures
To safeguard children from infection, prioritize these actions:
- Masking in crowded indoor spaces.
- Frequent hand hygiene and surface cleaning.
- Check vaccination updates and booster eligibility.
- Promote school-level awareness and ensure proper ventilation.
What Parents Should Know
As of April 6th, 2026, there are no reported hospitalizations due to the new subvariant.
Seek medical help if children exhibit a combination of symptoms. Home care can manage mild symptoms, but consultation is advisable if there's a risk of infection due to travel.
Focus on vigilance, not panic. Keep vaccinations up to date and track the disease's spread. Community-level prevention strategies are crucial.
What to Watch Next
The WHO continues to closely monitor the 'Cicada' variant. Further research is needed to fully understand its transmissibility and severity, especially in children. Keep an eye on official updates from the MoHFW and ICMR.